Pil Ho KIM
Inventor
Stats
- 14 US patents issued
- 27 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 14 US Patents Issued
- 27 US Applications Filed
- 92 Total Citation Count
- Nov 15, 2024 Most Recent Filing
- Jun 2, 2009 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
CHEIL INDUSTRIES INC. | 1
| 2013
|
LOTTE ADVANCED MATERIALS CO., LTD. | 4
2 3 4 4 6 | 2009
2010 2011 2012 2013 2014 |
KATHOLIEKE UNIVERSITEIT LEUVEN | 4
2 | 2012
2016 |
KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. | 1
| 2012
|
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY | 4
2 | 2012
2016 |
Inventor Addresses
Address | Duration |
---|---|
Daejeon, KR | Apr 24, 14 - Mar 13, 25 |
Daejeongwangyeok-si, KR | Sep 24, 09 - Dec 14, 10 |
Gunpo-si, KR | Dec 27, 12 - Oct 06, 15 |
Seoul, KR | Aug 04, 16 - Aug 04, 16 |
Uiwang-si, KR | Jun 24, 10 - Jun 07, 22 |
Yongin-si, KR | Jan 12, 23 - Jul 04, 23 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
B32B: | LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0082,762 | 2025 | NOVEL BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF | 0 |
2025/0073,341 | 2025 | BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF | 0 |
12161722 | 2024 | Bifunctional heterocyclic compound having BTK degradation function via ubiquitin proteasome pathway, and use thereof | 0 |
2024/0285,778 | 2024 | NOVEL BIFUNCTIONAL HETEROCYCLIC COMPOUND HAVING BTK DEGRADATION FUNCTION VIA UBIQUITIN PROTEASOME PATHWAY, AND USE THEREOF | 0 |
2024/0270,698 | 2024 | NOVEL PYRIMIDINE DERIVATIVE AND USE THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.